NEWS COMMENTARY

Cognoa prepares the ground with initial FDA approval for multipronged market approach

Published:
June 16, 2021
Services:
CPG More...
Priorities:
“Better-for-You” Transformation More...
Activities:
Policy More...
by Danielle Bradnan
Very important

This is an important development not only from the care perspective – as early identification of autism is critical to helping children yet is often stymied by lack of access – but from a market perspective. Cognoa is building an ecosystem for autism that considers the patient journey. By starting with a diagnostic tool targeted at pediatricians, it prepares the ground for its next product, a tool that helps autistic children self-manage. By decentralizing both the diagnostic and the treatment, Cognoa is considering multiple challenges in the patient journey and creating a powerful market position in doing so. Clients looking to engage in healthcare should learn from this and develop a multipronged approach for addressing consumer needs.

For the original news article, click here .


Further Reading

Recovering COVID-19 patients may face higher risk of developing blood clots

News Commentary | April 14, 2021

Scientists at Singapore's Nanyang Technological University reported that recovering COVID‑19 patients with preexisting cardiovascular conditions may be at a higher risk of developing blood clots. The findings come at a time when vaccines from AstraZeneca and Johnson & Johnson have reported rare ... Not part of subscription

InteliCare receives $70,000 grant to build machine learning-based health prediction software for the elderly

News Commentary | June 10, 2021

In partnership with Macquarie University and the University of Sydney, InteliCare is aiming to create a product that can predict healthcare outcomes around elderly patients. The idea behind the system is to be able to predict aging concerns like chronic disease, falls, and dementia in time to alert ... Not part of subscription

AliveCor rolling out a credit-card-sized ECG machine

News Commentary | February 07, 2022

AliveCor, creators of the six‑lead ECG (electrocardiogram) system KardiaMobile 6L have gone even smaller. The credit‑card‑sized ECG machine is designed to fit in users' wallets while still accurately detecting six types of arrhythmia. The device is FDA approved to detect atrial fibrillation, ... Not part of subscription